New threat for biotechs -- Europe

Fikes, Bradley J.
October 1994
San Diego Business Journal;10/10/94, Vol. 15 Issue 41, p1
Reports on the potential competition posed by biotechnology companies in Europe to the United States biotechnology industry. Simplification of approval process for biotech drugs by the European Community to encourage drug manufacturers and to entice other manufacturers to set up plants in Europe; Regulations of the United States Food & Drug Administration (FDA) as barriers in developing products.


Related Articles

  • Quide3l gains FDA approval for rapid flu test. Webb // San Diego Business Journal;10/11/99, Vol. 20 Issue 41, p29 

    Cites developments concerning biotechnology companies in the San Diego, California area as of October 11, 1999. Includes Quidel Corp.'s receipt of government approval for the marketing of its QuickVue Influenza Test in the United States; Idec Pharmaceuticals Corp.'s testing of the Idec-114 drug...

  • Employment and management trends in the biotechnolgy industry. Larbey, Cynthia // Journal of Commercial Biotechnology;Spring2002, Vol. 8 Issue 4, p298 

    This paper takes a look at the major influences on the biotechnology industry and how they are currently affecting employment and management trends. It takes a brief look at the impact of the economic environment, the pharmaceutical industry, the role of geography, the employment stages faced by...

  • Financing Picks Up. Burrill, G. Steven // BioPharm International;Sep2001, Vol. 14 Issue 9, p48 

    Discusses the financial recovery of biotechnology companies in the United States and Europe. Predictions regarding increased merger and acquisition activity within the industry; Market value of the U.S. biotechnology market; Prediction that investments in the industry is likely to improve in...

  • Biopharmaceuticals set for change.  // Chemical Market Reporter;04/07/97, Vol. 251 Issue 14, p7 

    Cites the changes in store for the biopharmaceutical industry in the United States as gleaned from study conducted by Decision Resources. Change in relationships with biotechnology companies; Investment in smaller biotechnology-oriented companies; Changing technological base of the...

  • Pharmaceutical and Biotech Sectors Drive Cleanroom Market Growth. Miller, George // Pharmaceutical Technology;Mar2003, Vol. 27 Issue 3, p20 

    Discusses the impact of technology advances and market growth in the pharmaceutical and biotechnology fields on the contamination control market in the U.S. Forecasted sales of cleanroom hardware and consumables worldwide by 2004; Forecasted value of worldwide cleanroom consumables market in...

  • Pharmaceutical Scientists in Today's Job Market . . . . Part I: An Industry in Turmoil. Dougherty, Eileen; Joslin, Robert S. // Pharmaceutical Technology;Mar2003, Vol. 27 Issue 3, p228 

    Part I. Outlines the profile of the pharmaceutical and biotechnology industries in the U.S., in 2003. Economic and political factors affecting the performance of the industry; Key to investments in research and development; Impact of the radical changes on employment opportunities and career...

  • An Industry Comes of Age. Robinson, Kevin // BioPharm International;Nov2002, Vol. 15 Issue 11, p20 

    Offers a look at the progress of biotechnology industries in Europe as of 2002. Revenues of the industry in 2000; Relationship between the pharmaceutical and the biotechnology industries; Factors which have contributed to the growth of the industry.

  • ...but seeks `practical' gene therapy deals. Lehrman, Sally // Nature;11/2/1995, Vol. 378 Issue 6552, p7 

    Reports on the support of pharmaceutical companies for gene-based medicine. Discouraging clinical trials for experimental gene therapies; Hoecgst Marion Roussel (HMR); Background information; Rhone Poulenc Rorer (RPR); Implications; SmithKline Beecham; Expectations.

  • Containment Levels and Facility Design. Pearson, Ian // Pharmaceutical Technology Europe;Feb2003, Vol. 15 Issue 2, p24 

    Discusses factors to be considered when planning a containment facility for biotechnology and pharmaceutical companies. Main areas of application for containment facilities; Facility containment levels for the control of biological agents; Planning and design strategy for containment...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics